Population Pharmacokinetic Assessment of Vancomycin Dosing in the Large Pediatric Patient

Area of Science:

• Pharmacology
• Pediatric Medicine
• Pharmacokinetics

Background:

• Optimal vancomycin dosing in pediatric patients weighing ≥70 kg remains unclear.
• Achieving target area under the concentration-time curve (AUC) of ≥400 mg·liter/h and trough concentration <20 mg/liter is critical for efficacy and safety.

Purpose of the Study:

• To determine the most appropriate vancomycin dosing strategy (weight-based vs. non-weight-based) in pediatric patients weighing ≥70 kg.
• To identify dosing parameters that ensure therapeutic vancomycin exposure.

Main Methods:

• Population pharmacokinetic analysis was employed.
• The study evaluated vancomycin dosing strategies in relation to patient weight and kidney function.

Main Results:

• Weight-based vancomycin dosing, utilizing fat-free mass, was identified as the optimal strategy.
• Adjustments for kidney dysfunction are necessary for accurate dosing.

Conclusions:

• Vancomycin dosing in pediatric patients ≥70 kg should be weight-based, calculated using fat-free mass.
• Renal function must be considered to optimize vancomycin dosing and achieve target therapeutic levels.